<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 12.25pt 6pt 0; text-align: center"><B>As Filed with the Securities
and Exchange Commission on June 18, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="text-underline-style: double"><B><U>&#9;Registration
No. 333-198479&#9;</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>POST-EFFECTIVE AMENDMENT NO. 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM S-8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Registration
Statement Under The Securities Act of 1933</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>RICH
PHARMACEUTICALS, INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Exact name of registrant as specified in its
charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Nevada</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction of</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">incorporation or organization)</P></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>46-3259117</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(I.R.S. Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification No.)</P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>9595 Wilshire Blvd, Suite 900</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Beverly Hills, California</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of Principal Executive Offices)</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>90212</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Zip Code)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>The Rich Pharmaceuticals, Inc. 2013 Equity
Incentive Plan, as amended</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0">(Full title of the plan)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Ben Chang<BR>
Chief Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Rich Pharmaceuticals, Inc.<BR>
9595 Wilshire Blvd, Suite 900</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Beverly Hills, California 90212</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">(Name and Address of Agent
For Service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(323) 424-3169</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0">(Telephone number, including
area code, of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0">Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; and &ldquo;smaller reporting company&rdquo;
in Rule&nbsp;12b-2 of the Exchange Act. (Check one):</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">Large&nbsp;Accelerated&nbsp;filer&nbsp;&#9744;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">Accelerated&nbsp;filer&nbsp;&#9744;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="width: 18%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">Non-accelerated&nbsp;filer&nbsp;&#9744;</FONT><BR>
<FONT STYLE="font-size: 10pt">(Do not check if a smaller reporting company)</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="width: 27%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">Smaller reporting company&nbsp;&#9744;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>This Post-Effective Amendment No.
1 is being filed to reflect that the number of shares of common stock, par value $0.001 per share, of Rich Pharmaceuticals, Inc.
covered by this Registration Statement is increased from 15,000,000 to 390,004,800</B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>CALCULATION OF REGISTRATION FEE</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 0.7pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title&nbsp;of&nbsp;&nbsp;Securities&nbsp;to&nbsp;be&nbsp;Registered</B></FONT></TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center"></TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Amount&nbsp;to&nbsp;be</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Registered&nbsp;(1)(2)</B></FONT></TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center"></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proposed</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Maximum</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Offering&nbsp;Price&nbsp;</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Per&nbsp;Share (3)</B></FONT></TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center"></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Proposed&nbsp;Maximum</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Aggregate&nbsp;Offering</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Price (3)</B></FONT></TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center"></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0.7pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Amount&nbsp;of&nbsp;</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Registration&nbsp;Fee</B></FONT></TD>
    <TD STYLE="padding-right: 0.7pt; text-align: center"></TD></TR>
<TR STYLE="background-color: rgb(204,238,204)">
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; padding-right: 0.7pt; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-size: 10pt">Common Stock, par value $0.001 per share</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 0.7pt"></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 0.7pt; text-align: right"><FONT STYLE="font-size: 10pt">375,004,800</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 0.7pt"></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 0.7pt; text-align: right"><FONT STYLE="font-size: 10pt">0.0003</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 0.7pt; text-align: right"></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-left: 0.5in; text-align: right; text-indent: -0.5in"><FONT STYLE="font-size: 10pt">$</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 0.7pt; text-align: right"><FONT STYLE="font-size: 10pt">112,501</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 0.7pt"></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; text-align: right"></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 0.7pt; text-align: right"><FONT STYLE="font-size: 10pt">$13.07</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: Black 1pt solid; padding-right: 0.7pt"></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 0.7pt"></TD>
    <TD STYLE="width: 95%; padding-right: 0.7pt; text-align: justify"><FONT STYLE="font-size: 10pt">This Post-Effective Amendment No.1 to the Registration Statement on Form S-8 (File No. 333-198479) for Rich Pharmaceuticals, Inc. (the &ldquo;Company&rdquo;) covers an additional 375,0004,800 shares (the &ldquo;Additional Shares&rdquo;) of Common Stock, par value $0.001 per share (the &ldquo;Common Stock&rdquo;) to be issued as Stock Awards under the Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan, as amended (the &ldquo;2013 Plan&rdquo;).&nbsp;&nbsp;An aggregate of 390,004,800 shares of the Company&rsquo;s Common Stock have been or may be issued as Stock Awards under the 2013 Plan. Of the 390,004,800 shares, 15,000,000 shares were previously registered (the &ldquo;Previously Registered Shares&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;) pursuant to the Company&rsquo;s Registration Statement on Form S-8 (File No. 333-198479) filed with the Securities and Exchange Commission on August 29, 2014.&nbsp;&nbsp;The registration fee for the Additional Shares is $13.07. The Company previously paid the registration fee for the Previously Registered Shares.&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt"></TD>
    <TD STYLE="padding-right: 0.7pt; text-align: justify"><FONT STYLE="font-size: 10pt">Pursuant to Rule 416 of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), this Registration Statement shall also cover any additional shares of Common Stock which become issuable under the 2013 Plan by reason of any stock split, stock dividend, recapitalization or any other similar transaction effected without receipt of consideration, which results in an increase in the Registrant&rsquo;s outstanding shares of Common Stock.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.7pt"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="padding-right: 0.7pt"></TD>
    <TD STYLE="padding-right: 0.7pt; text-align: justify"><FONT STYLE="font-size: 10pt">Estimated pursuant to Rules 457(c) and 457(h) under the Securities Act, solely for the purpose of calculating the registration fee, based on the closing price of the Common Stock as reported OTC Markets on June 16, 2015.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">&nbsp;<BR>
The Registration Statement shall become effective
upon filing in accordance with Rule 462(a) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">Rich Pharmaceuticals,
Inc. (the &ldquo;Company&rdquo;) previously filed a Registration Statement on Form S-8 (File No. 333-198479), as amended by this
Post-Effective Amendment No. 1 (&ldquo;Amendment No. 1&rdquo;) to the Registration Statement on Form S-8 (the &ldquo;Prior Registration
Statement&rdquo;), relating to the Company&rsquo;s 2013 Stock Incentive Plan (the &ldquo;2013 Plan&rdquo;). Under the Prior Registration
Statement, the Registrant registered an aggregate of 15,000,000 shares of common stock, par value $0.001 per share (&ldquo;Common
Stock&rdquo;) to be offered and sold under the 2013 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">This Post-Effective Amendment
No. 1 is filed pursuant to General Instruction E of Form S-8 and relates to the Prior Registration Statement. Except for the changes
set forth herein, the contents of the Prior Registration Statement, including each of the documents filed with the Securities and
Exchange Commission (the &ldquo;Commission&rdquo;), are incorporated by reference herein. In addition, all exhibits required by
General Instruction E of Form S-8 are filed as exhibits hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">PART II</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">INFORMATION REQUIRED IN REGISTRATION
STATEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 5. Interests of Named Experts and Counsel.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt">&#9;None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><B>Item 8.&#9;Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in; text-align: left"><FONT STYLE="font-weight: normal">See
Exhibit Index.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Pursuant to the
requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to Form S-8 Registration
Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Beverly Hills, State of California,
on June 18, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><B>RICH PHARMACEUTICALS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&#9;By: <U>/s/Ben Chang &#9;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&#9;&#9; Ben Chang &#9;&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 24pt; text-indent: 0.5in">Chief Executive Officer</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">POWER OF ATTORNEY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>KNOW ALL PERSONS
BY THESE PRESENTS</B>, that each of the undersigned officers and directors of RICH PHARMACEUTICALS, INC., a Nevada corporation
(the &ldquo;Company&rdquo;), hereby nominates and appoints Ben Chang and Tsailing Chang, and each of them acting or signing singly,
as his agents and attorneys-in-fact (the &ldquo;Agents&rdquo;), in his respective name and in the capacity or capacities indicated
below, to execute and/or file, with all exhibits thereto, and other documents filed in connection therewith or constituting a part
thereof: (1) a registration statement on Form S-8 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;),
in connection with the registration under the Securities Act of shares of Common Stock of the Company to be issued in connection
with the Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan, as amended, and (2) any one or more amendments to any part of the
foregoing registration statement, including any post-effective amendments, or appendices or supplements that may be required to
be filed under the Securities Act to keep such registration statement effective or to terminate its effectiveness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Further, the undersigned
do hereby authorize and direct such agents and attorneys-in-fact to take any and all actions and execute and file any and all documents
with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) or state regulatory agencies, necessary, proper or convenient
in their opinion to comply with the Securities Act and the rules and regulations or orders of the SEC, or state regulatory agencies,
adopted or issued pursuant thereto, to the end that the registration statement of the Company shall become effective under the
Securities Act and any other applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">Finally, each of
the undersigned does hereby ratify, confirm and approve each and every act and document which the said appointment agents and attorneys-in-fact
may take, execute or file pursuant thereto with the same force and effect as though such action had been taken or such documents
had been executed or filed by the undersigned respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Power of Attorney
shall remain in full force and effect until revoked or superseded by written notice filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF,
</B>each of the undersigned has executed this Power of Attorney as of the date indicated. Pursuant to the requirements of the Securities
Act this Post-Effective Amendment No. 1 to Form S-8 Registration Statement has been signed by the following persons in the capacities
and on the date indicated.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%"><FONT STYLE="font-size: 10pt">Dated: June 18, 2015</FONT></TD>
    <TD STYLE="width: 70%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Ben Chang</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-size: 10pt">Ben Chang</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer, Interim Chief Financial Officer and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Dated: June 18, 2015</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ David Chou</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-size: 10pt">David Chou</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD></TD>
    <TD><FONT STYLE="font-size: 10pt">Director</FONT></TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">INDEX TO EXHIBITS&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 12%; padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="vertical-align: bottom; width: 86%; padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Description of Document</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">Articles of Incorporation (1)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">Bylaws (1)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">Certificate of Designations of Series A Preferred Stock, dated July 18, 2013 (2)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">3.4</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">Articles of Merger (3)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">3.5</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">Amendment to Articles of Incorporation (4)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><A HREF="ex5_1.htm"><FONT STYLE="font-size: 10pt">Opinion of The Doney Law Firm</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 0"><FONT STYLE="font-size: 10pt"><A HREF="ex23_1.htm">Consent of Silberstein Ungar, PLLC</A></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">23.3</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">Consent of The Doney Law Firm (included in Exhibit 5.1).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0; text-align: justify"><FONT STYLE="font-size: 10pt">24.1</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">Power of Attorney (included as part of the signature page to this Registration Statement).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0; text-align: justify"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"><FONT STYLE="font-size: 10pt">Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan (5)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0; text-align: justify"><FONT STYLE="font-size: 10pt">99.2</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Form of Notice of Grant for the 2013 Equity Incentive Plan (5)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 0; text-align: justify"><FONT STYLE="font-size: 10pt">99.3</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Amendment No. 1 dated October 6, 2014 to Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan (6) </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 0; text-align: justify"><FONT STYLE="font-size: 10pt">99.4</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2pt; padding-bottom: 2pt; text-align: justify"></TD>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Amendment No. 2 dated April 6, 2015 to Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan (7)</FONT></TD></TR>
</TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">                                                                                                                                      <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>(1)</TD><TD>Incorporated by reference to the Company&rsquo;s Registration Statement Filed on Form S-1 filed with the SEC on April 25, 2011.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 2.4pt">(2)</TD><TD>Incorporated by reference to the Company&rsquo;s Form 8-K filed with the SEC on July 24, 2013.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 2.4pt">(3)</TD><TD>Incorporated by reference to the Company&rsquo;s Form 8-K filed with the SEC on August 27, 2013.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 2.4pt">(4)</TD><TD>Incorporated by reference to the Company&rsquo;s Form 8-K filed with the SEC on October 2, 2013.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 2.4pt">(5)</TD><TD>Incorporate by reference to the Company&rsquo;s Form S-8 filed with the SEC on August 29, 2014.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 2.4pt">(6)</TD><TD>Incorporated by reference to the Company&rsquo;s Form 8-K filed with the SEC on October 8, 2014.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 2.4pt">(7)</TD><TD>Incorporated by reference to the Company&rsquo;s Form 8-K filed with the SEC on April 8, 2015.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; border-top: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "mainbody.htm", "description": "MAINBODY", "secsgml_size_bytes": 35230}]
{"company-data": {"conformed-name": "Rich Pharmaceuticals, Inc.", "cik": "0001504389", "assigned-sic": "2834", "irs-number": "463259117", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-205074", "film-number": "15940810"}, "business-address": {"street1": "9595 WILSHIRE BLVD., SUITE 900", "city": "BEVERLY HILLS", "state": "CA", "zip": "90212", "phone": "(424) 230-7001"}, "mail-address": {"street1": "9595 WILSHIRE BLVD., SUITE 900", "city": "BEVERLY HILLS", "state": "CA", "zip": "90212"}, "former-company": {"former-conformed-name": "Nepia Inc.", "date-changed": "20101027"}}
As Filed with the Securities
and Exchange Commission on June 18, 2015
Registration
No. 333-198479
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
Registration
Statement Under The Securities Act of 1933
RICH
PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its
charter)
Nevada
(State or other jurisdiction of
incorporation or organization)
46-3259117
(I.R.S. Employer
Identification No.)
9595 Wilshire Blvd, Suite 900
Beverly Hills, California
(Address of Principal Executive Offices)
90212
(Zip Code)
The Rich Pharmaceuticals, Inc. 2013 Equity
Incentive Plan, as amended
(Full title of the plan)
Ben Chang
Chief Executive Officer
Rich Pharmaceuticals, Inc.
9595 Wilshire Blvd, Suite 900
Beverly Hills, California 90212
(Name and Address of Agent
For Service)
(323) 424-3169
(Telephone number, including
area code, of agent for service)
Indicate by check mark
whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.
See the definitions of "large accelerated filer," "accelerated filer," and "smaller reporting company"
in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated filer ☐
Accelerated filer ☐
Non-accelerated filer ☐
(Do not check if a smaller reporting company)
Smaller reporting company ☐
This Post-Effective Amendment No.
1 is being filed to reflect that the number of shares of common stock, par value $0.001 per share, of Rich Pharmaceuticals, Inc.
covered by this Registration Statement is increased from 15,000,000 to 390,004,800
CALCULATION OF REGISTRATION FEE
Title of  Securities to be Registered
Amount to be
Registered (1)(2)
Proposed
Maximum
Offering Price
Per Share (3)
Proposed Maximum
Aggregate Offering
Price (3)
Amount of
Registration Fee
Common Stock, par value $0.001 per share
375,004,800
$
0.0003
$
112,501
$13.07
(1)
This Post-Effective Amendment No.1 to the Registration Statement on Form S-8 (File No. 333-198479) for Rich Pharmaceuticals, Inc. (the "Company") covers an additional 375,0004,800 shares (the "Additional Shares") of Common Stock, par value $0.001 per share (the "Common Stock") to be issued as Stock Awards under the Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan, as amended (the "2013 Plan").  An aggregate of 390,004,800 shares of the Company's Common Stock have been or may be issued as Stock Awards under the 2013 Plan. Of the 390,004,800 shares, 15,000,000 shares were previously registered (the "Previously Registered Shares") under the Securities Act of 1933, as amended (the "Securities Act") pursuant to the Company's Registration Statement on Form S-8 (File No. 333-198479) filed with the Securities and Exchange Commission on August 29, 2014.  The registration fee for the Additional Shares is $13.07. The Company previously paid the registration fee for the Previously Registered Shares.
(2)
Pursuant to Rule 416 of the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of Common Stock which become issuable under the 2013 Plan by reason of any stock split, stock dividend, recapitalization or any other similar transaction effected without receipt of consideration, which results in an increase in the Registrant's outstanding shares of Common Stock.
(3)
Estimated pursuant to Rules 457(c) and 457(h) under the Securities Act, solely for the purpose of calculating the registration fee, based on the closing price of the Common Stock as reported OTC Markets on June 16, 2015.
The Registration Statement shall become effective
upon filing in accordance with Rule 462(a) under the Securities Act.
EXPLANATORY NOTE
Rich Pharmaceuticals,
Inc. (the "Company") previously filed a Registration Statement on Form S-8 (File No. 333-198479), as amended by this
Post-Effective Amendment No. 1 ("Amendment No. 1") to the Registration Statement on Form S-8 (the "Prior Registration
Statement"), relating to the Company's 2013 Stock Incentive Plan (the "2013 Plan"). Under the Prior Registration
Statement, the Registrant registered an aggregate of 15,000,000 shares of common stock, par value $0.001 per share ("Common
Stock") to be offered and sold under the 2013 Plan.
This Post-Effective Amendment
No. 1 is filed pursuant to General Instruction E of Form S-8 and relates to the Prior Registration Statement. Except for the changes
set forth herein, the contents of the Prior Registration Statement, including each of the documents filed with the Securities and
Exchange Commission (the "Commission"), are incorporated by reference herein. In addition, all exhibits required by
General Instruction E of Form S-8 are filed as exhibits hereto.
2
PART II
INFORMATION REQUIRED IN REGISTRATION
STATEMENT
Item 5. Interests of Named Experts and Counsel.
None.
Item 8.	Exhibits.
See
Exhibit Index.
SIGNATURES
Pursuant to the
requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that
it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to Form S-8 Registration
Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Beverly Hills, State of California,
on June 18, 2015.
RICH PHARMACEUTICALS, INC.
By:
/s/Ben Chang
Ben Chang
Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL PERSONS
BY THESE PRESENTS
, that each of the undersigned officers and directors of RICH PHARMACEUTICALS, INC., a Nevada corporation
(the "Company"), hereby nominates and appoints Ben Chang and Tsailing Chang, and each of them acting or signing singly,
as his agents and attorneys-in-fact (the "Agents"), in his respective name and in the capacity or capacities indicated
below, to execute and/or file, with all exhibits thereto, and other documents filed in connection therewith or constituting a part
thereof: (1) a registration statement on Form S-8 under the Securities Act of 1933, as amended (the "Securities Act"),
in connection with the registration under the Securities Act of shares of Common Stock of the Company to be issued in connection
with the Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan, as amended, and (2) any one or more amendments to any part of the
foregoing registration statement, including any post-effective amendments, or appendices or supplements that may be required to
be filed under the Securities Act to keep such registration statement effective or to terminate its effectiveness.
Further, the undersigned
do hereby authorize and direct such agents and attorneys-in-fact to take any and all actions and execute and file any and all documents
with the Securities and Exchange Commission (the "SEC") or state regulatory agencies, necessary, proper or convenient
in their opinion to comply with the Securities Act and the rules and regulations or orders of the SEC, or state regulatory agencies,
adopted or issued pursuant thereto, to the end that the registration statement of the Company shall become effective under the
Securities Act and any other applicable law.
Finally, each of
the undersigned does hereby ratify, confirm and approve each and every act and document which the said appointment agents and attorneys-in-fact
may take, execute or file pursuant thereto with the same force and effect as though such action had been taken or such documents
had been executed or filed by the undersigned respectively.
This Power of Attorney
shall remain in full force and effect until revoked or superseded by written notice filed with the SEC.
IN WITNESS WHEREOF,
each of the undersigned has executed this Power of Attorney as of the date indicated. Pursuant to the requirements of the Securities
Act this Post-Effective Amendment No. 1 to Form S-8 Registration Statement has been signed by the following persons in the capacities
and on the date indicated.
Dated: June 18, 2015
/s/ Ben Chang
Ben Chang
Chief Executive Officer, Interim Chief Financial Officer and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
Dated: June 18, 2015
/s/ David Chou
David Chou
Director
3
INDEX TO EXHIBITS
Exhibit No.
Description of Document
3.1
Articles of Incorporation (1)
3.2
Bylaws (1)
3.3
Certificate of Designations of Series A Preferred Stock, dated July 18, 2013 (2)
3.4
Articles of Merger (3)
3.5
Amendment to Articles of Incorporation (4)
5.1
Opinion of The Doney Law Firm
23.1
Consent of Silberstein Ungar, PLLC
23.3
Consent of The Doney Law Firm (included in Exhibit 5.1).
24.1
Power of Attorney (included as part of the signature page to this Registration Statement).
99.1
Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan (5)
99.2
Form of Notice of Grant for the 2013 Equity Incentive Plan (5)
99.3
Amendment No. 1 dated October 6, 2014 to Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan (6)
99.4
Amendment No. 2 dated April 6, 2015 to Rich Pharmaceuticals, Inc. 2013 Equity Incentive Plan (7)
(1)
Incorporated by reference to the Company's Registration Statement Filed on Form S-1 filed with the SEC on April 25, 2011.
(2)
Incorporated by reference to the Company's Form 8-K filed with the SEC on July 24, 2013.
(3)
Incorporated by reference to the Company's Form 8-K filed with the SEC on August 27, 2013.
(4)
Incorporated by reference to the Company's Form 8-K filed with the SEC on October 2, 2013.
(5)
Incorporate by reference to the Company's Form S-8 filed with the SEC on August 29, 2014.
(6)
Incorporated by reference to the Company's Form 8-K filed with the SEC on October 8, 2014.
(7)
Incorporated by reference to the Company's Form 8-K filed with the SEC on April 8, 2015.
4